Neuroscience. Deconstructing schizophrenia.
Holden
Constance
C
D001288:Attention; D044383:Black People / Q000235:genetics; D001921:Brain / Q000473:pathology / Q000503:physiopathology; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D065098:Catechol O-Methyltransferase Inhibitors; D003071:Cognition; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005190:Family; D006801:Humans; D008568:Memory; D009483:Neuropsychological Tests; D018377:Neurotransmitter Agents / Q000378:metabolism; D010641:Phenotype; D011619:Psychotropic Drugs / Q000627:therapeutic use; D040641:Quantitative Trait Loci; D011978:Receptors, Nicotinic / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics / Q000503:physiopathology; D012565:Schizophrenic Psychology; D044465:White People / Q000235:genetics
D065098:Catechol O-Methyltransferase Inhibitors; D004791:Enzyme Inhibitors; D018377:Neurotransmitter Agents; D011619:Psychotropic Drugs; D011978:Receptors, Nicotinic; D002394:Catechol O-Methyltransferase